Client of a consultant lobbyist
Moderna Biopharma Canada Corporation
- Meetings this Parliament
- 0
- With MPs
- 0
- Since Nov 2021
- 0
- Active registrations
- 1
Lobbying by Moderna Biopharma Canada Corporation: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Consultant In effect since Mar 1, 2026 Receives government funding
Consultant Natalie Sutton of Barrack Hill Public Affairs Inc.
Consultant lobbyists
- Natalie Sutton
Institutions they may lobby: Federal Economic Development Agency for Southern Ontario (FedDev), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Prairies Economic Development Canada (PrairiesCan), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC), Treasury Board Of Canada Secretariat (TBS)
What they're lobbying on (5)Hide details
- Communicating with government officials about vaccine production, more specifically opportunities to increase biomanufacturing capabilities in Canada.
- Communicating with government officials about procurement polices and procedures (including, but not limited to, those maintained by the Departments of Health and Public Services and Procurement), more specifically policies and procedures pertaining to the development, procurement and distribution of vaccines, including Moderna's messenger ribonucleic acid ("mRNA") vaccines.
- Communicating with government officials about pandemic and emergency planning, including the "Pandemic Preparedness Plan" being prepared by the Public Health Agency of Canada ("PHAC").
- Communicating with government officials, in general, about pharmaceutical and biotechnology policies, including those related to innovation, research and development and messenger ribonucleic acid ("mRNA") biotechnology.
- Communicating with government officials, in general, about pharmaceutical and biotechnology policies, including those related to innovation, research and development and messenger ribonucleic acid ("mRNA") biotechnology.
Registration 963151-385046-1. Look it up in the official Registry
Reported meetings
No meetings reported since November 2021.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.